News | January 20, 2026
Mahajan Imaging & Labs launches AI-driven blood test to detect Alzheimer’s early
Over 8.8?million Indians aged 60 and above currently live with dementia,
Over 8.8?million Indians aged 60 and above currently live with dementia,
The deal to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) underscores Bayer’s commitment to expanding in molecular imaging and advancing precision cardiology
The acquisition of AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) positions Bayer at the forefront of cardiac amyloidosis diagnostics
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
Facility designed to advance the next generation of imaging systems
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64
Subscribe To Our Newsletter & Stay Updated
